| P2093 | author name string | Cuicui Liu | |
| | Liguo Yang | |
| | Zhiqiang Yan | |
| | Juanjuan Tan | |
| P2860 | cites work | MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein | Q24601263 |
| | MicroRNAs: target recognition and regulatory functions | Q24609584 |
| | Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3β | Q24610983 |
| | MicroRNA-26a is a novel regulator of vascular smooth muscle cell function | Q24624403 |
| | The role of miR-26 in tumors and normal tissues (Review) | Q24629056 |
| | Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters | Q24645192 |
| | The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation | Q24650204 |
| | Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 |
| | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 |
| | Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation | Q24683060 |
| | Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis | Q77381388 |
| | Isolation of vascular smooth muscle cells from a single murine aorta | Q78675064 |
| | MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation | Q82284786 |
| | Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma | Q38785857 |
| | MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin | Q39123359 |
| | miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. | Q39135735 |
| | A functional link between the human cell cycle-regulatory phosphatase Cdc14A and the atypical mitogen-activated kinase Erk3. | Q40018603 |
| | Pathophysiology of vein graft failure: A review | Q40476385 |
| | Increase in neuroexcitability of unmyelinated C-type vagal ganglion neurons during initial postnatal development of visceral afferent reflex functions | Q46198657 |
| | MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway | Q47616223 |
| | MicroRNA-34a targets Forkhead box j2 to modulate differentiation of endothelial progenitor cells in response to shear stress. | Q50320371 |
| | 14-3-3epsilon inhibits MK5-mediated cell migration by disrupting F-actin polymerization. | Q50337030 |
| | Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. | Q53332426 |
| | The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling. | Q53407049 |
| | Enhanced cell cycle entry and mitogen-activated protein kinase-signaling and downregulation of matrix metalloproteinase-1 and -3 in human diabetic arterial vasculature. | Q53569704 |
| | Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery | Q70990064 |
| | Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling | Q76380614 |
| | The functions of animal microRNAs | Q27860621 |
| | Regulation of microRNA biogenesis | Q28243976 |
| | MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin | Q28263940 |
| | Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer | Q28295895 |
| | The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology | Q28504513 |
| | MAP kinases | Q28679111 |
| | Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions | Q29547189 |
| | Molecular regulation of vascular smooth muscle cell differentiation in development and disease | Q29615194 |
| | Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease | Q30454529 |
| | Cyclin D1 is a bona fide target gene of NFATc1 and is sufficient in the mediation of injury-induced vascular wall remodeling. | Q33661435 |
| | Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications | Q33712421 |
| | Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship | Q33719798 |
| | MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling | Q33799083 |
| | The insulin-like growth factor axis: A review of atherosclerosis and restenosis | Q33832995 |
| | Nuclear export of ERK3 by a CRM1-dependent mechanism regulates its inhibitory action on cell cycle progression | Q34221836 |
| | Role of microRNAs in vascular diseases, inflammation, and angiogenesis | Q34786294 |
| | MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma | Q35032496 |
| | MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis | Q35210429 |
| | Desmin regulates airway smooth muscle hypertrophy through early growth-responsive protein-1 and microRNA-26a | Q35604477 |
| | High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression | Q35625038 |
| | MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways | Q35678702 |
| | PDGF signaling in cells and mice | Q35811080 |
| | Counting on mitogen-activated protein kinases--ERKs 3, 4, 5, 6, 7 and 8. | Q35894166 |
| | Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. | Q36357770 |
| | Training a sophisticated microsurgical technique: interposition of external jugular vein graft in the common carotid artery in rats | Q36462254 |
| | Vagus-brain communication in atherosclerosis-related inflammation: a neuroimmunomodulation perspective of CAD. | Q36652341 |
| | Application of mutated miR-206 target sites enables skeletal muscle-specific silencing of transgene expression of cardiotropic AAV9 vectors. | Q36883822 |
| | Emerging role of microRNAs in cardiovascular biology. | Q37026583 |
| | microRNAs in cardiovascular development | Q37039607 |
| | MicroRNAs: role in cardiovascular biology and disease | Q37161374 |
| | Docking of PRAK/MK5 to the atypical MAPKs ERK3 and ERK4 defines a novel MAPK interaction motif | Q37339291 |
| | Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality | Q37377329 |
| | Vein graft failure: current clinical practice and potential for gene therapeutics | Q37997898 |
| | MicroRNAs for Restenosis and Thrombosis After Vascular Injury | Q38781948 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 46602 | |
| P577 | publication date | 2017-04-21 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia | |
| P478 | volume | 7 | |